WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective January 1, 2025, the company granted a non-qualified stock option to purchase 375,000 shares of its common stock to Caroline Hensley, its newly hired Chief Legal Officer, under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan. The stock option ...

WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective January 1, 2025, the company granted a non-qualified stock option to purchase 375,000 shares of its common stock to Caroline Hensley, its newly hired Chief Legal Officer, under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan. The stock option ...

Vancouver, BC, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0) (“Rockridge”) (the “Company”) is pleased to announce that Rockridge has obtained final orders of the Supreme Court of British Columbia approving the previously announced proposed statutory plans of arrangement under section 288 of the Business Corporations Act (British Columbia) (the “Arrangements”) pursuant to which Eros will acquire all of the issued and outstanding common shares of MAS ...

Company Overview - Interfor is a growth-oriented forest products company with operations in Canada and the United States [1] - The company has an annual lumber production capacity of approximately 4.7 billion board feet [1] - Interfor offers a diverse line of lumber products to customers globally [1] Recent Transaction - Interfor has completed the divestiture of its operations in Québec, Canada to Les Chantiers de Chibougamau Ltée [2] - The divested operations include sawmills in Val-d'Or and Matagami, as well as the Sullivan remanufacturing plant in Val-d'Or [2] Contact Information - Investor contacts include Rick Pozzebon, Executive Vice President & Chief Financial Officer, and Mike Mackay, Vice President, Corporate Development & Treasury [3] - Media contact is Svetlana Kayumova, Senior Manager, Corporate Affairs & Communications [3]

TORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) announced today the resignation of Robin van Poelje from, and the appointment of Laurie Schultz to, Lumine Group’s Board of Directors (“Board”). “We want to thank Robin for his contributions during his tenure with the Lumine Group Board. His guidance and support was invaluable and we wish him continued success in his future endeavors,” said Mark Miller, Chair of the Board. “With today’s announcement, we are excited to w ...

Wilmington, Delaware, Jan. 10, 2025 (GLOBE NEWSWIRE) --  Aimfinity Investment Corp. I (NASDAQ:AIMAU) (the "Company"), a blank check company incorporated as a Cayman Islands exempted company, today announced it has concluded an extraordinary general meeting of the shareholders (the "Extraordinary General Meeting") in lieu of an annual general meeting on January 9, 2025, which previously adjourned from December 30, 2024. At the Extraordinary General Meeting, the shareholders of the Company approved, by specia ...

CALGARY, AB, Jan. 10, 2025 /PRNewswire/ - Enbridge Inc. (TSX: ENB) (NYSE: ENB) (Enbridge or the Company) will host a conference call and webcast to provide a business update and review 2024 fourth quarter results on February 14, 2025, at 7 a.m. MT (9 a.m. ET). The conference call format will include prepared remarks from the executive team, followed by a question-and-answer session for the analyst and investor community only. Enbridge's media and investor relations teams will be available after the call for ...

Executive Appointment - Axogen Inc appointed Craig Swandal as Vice President of Operations, reporting to CEO Michael Dale and overseeing manufacturing, supply chain, and infrastructure strategies [1] - Craig Swandal has over 25 years of experience in global manufacturing leadership within the medical device sector, including roles at Tendyne (Abbott Labs), ATS Medical, and Gyrus Medical (Olympus) [2] - Swandal holds a Mini MBA in Medical Technology from St Thomas University and a Bachelor of Arts in Organizational Management and Communications from Concordia University [3] Equity Grant Details - Craig Swandal received an equity grant consisting of 58,000 Restricted Stock Units (RSUs) and 58,000 Performance Stock Units (PSUs) as an inducement for employment [4] - The RSUs vest over 4 years, with 50% vesting after the second year and 25% annually thereafter [5] - The PSUs vest based on company stock price performance goals between February 22, 2024, and February 22, 2027, with potential payouts ranging from 0% to 200% [5] Company Overview - Axogen is a global leader in developing surgical solutions for peripheral nerve injuries, focusing on nerve regeneration and repair [7] - The company's products are used in scheduled non-trauma procedures and emergent trauma procedures, addressing conditions like breast reconstruction, neuroma removal, and nerve decompression [8][9] Product Portfolio - Axogen's product portfolio includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, and Axoguard Nerve Cap [10] - These products are designed for peripheral nerve repair and are available in multiple countries including the United States, Canada, Germany, and the United Kingdom [10]

BROOKFIELD, Conn., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, announced today the appointment of George Macricostas to the position of Executive Chairman, effective January 6, 2025. Mr. Macricostas has over 30 years of technical and management experience in business operations and information technology. He has been a member of the Photronics Board of Directors since 2002, serving on the Nomination and Cybersecurity committee ...

NEW YORK, Jan. 10, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Visa Inc. (NYSE: V) between November 16, 2023, and September 23, 2024, both dates inclusive (the "Class Period"), of the important January 21, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.So what: If you purchased Visa securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs t ...